Ann: Quarterly Activities Report, page-6

Obviously Mymana progress has continued but encountered delays launching into China. Perhaps this will change very soon.

26 February 2018

https://smallcaps.com.au/bioxyne-colostrum-honey-health-product-chinese-market/

Biotech company Bioxyne Limited (ASX: BXN)has revealed it is working on plans to cast its novel New Zealand honey product into China, thereby capturing an overlooked portion of the nutritional consumer market that’s growing rapidly on the back of a thriving middle-class in southeast Asia and China in particular.

MYMANA is a unique formulation of colostrum, honey and dairy milk formula, sourced from New Zealand and “boosted with vitamins and minerals for sustained energy,” according to Bioxyne.

BXN are not limited to only the above.